June 2017 in “The Journal of Clinical Endocrinology and Metabolism” Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.
12 citations
,
October 1999 in “Journal of The American Academy of Dermatology”
July 1997 in “The Lancet” A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.
January 2005 in “Journal of Elinical Research” The two finasteride preparations are bioequivalent.
The article concludes that understanding the causes of hair loss and using continuous treatments like minoxidil and finasteride can help manage it, despite potential side effects.
January 2000 in “วารสารเภสัชวิทยา (Thai Journal of Pharmacology)” Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.
Finasteride significantly reduces prostate cancer risk.
Finasteride may help treat hair loss in postmenopausal women.
June 2026 in “The Journal of Sexual Medicine” Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.
June 2007 in “Nature Clinical Practice Urology” Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.
October 2023 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Using both minoxidil and finasteride together on the scalp works better for male hair loss than using either one alone.
2 citations
,
January 2011 in “Yearbook of Urology” Stopping finasteride can improve sperm count in infertile men.
Finasteride and dutasteride can harm male reproductive health, affecting sperm and causing sexual dysfunction.
19 citations
,
August 2000 in “International Journal of Dermatology” Minoxidil and finasteride can slow or halt hair loss, but may have side effects.
January 2020 in “The Journal of Sexual Medicine” Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.
October 2025 in “Reactions Weekly” Finasteride and dutasteride may cause depression and suicidal thoughts.
45 citations
,
January 2008 in “Drugs” Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.
Combining medications with scalp care and lifestyle changes boosts hair growth and reduces medication side effects.
June 1996 in “Archives of Dermatology” Using a mix of finasteride and minoxidil can significantly regrow hair in men with pattern baldness.
January 2025 in “Journal of Prescribing Practice”
14 citations
,
June 2014 in “Journal of Pharmaceutical Sciences” Formulation P-08-016 better targets hair follicles for baldness treatment.
30 citations
,
September 2016 in “BMJ” Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.
May 2025 in “Journal of Cosmetic Dermatology” Post-finasteride syndrome may be linked to pre-existing psychological issues, not just the drug.
August 2004 in “Medisch-Farmaceutische Mededelingen” Long-term use of finasteride may cause breast cancer in men.
61 citations
,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism”
September 2019 in “Journal of Investigative Dermatology” Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.
April 2023 in “European urology open science” Urologists should screen for mental health issues before and during finasteride treatment.
October 2025 in “International Journal of Social health” Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.
March 2009 in “The Journal of Urology” Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.
15 citations
,
January 2018 in “Acta dermato-venereologica” Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.